Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Marker Driven Selection of Patients for Prostate Biopsy and Management: The University of Miami MDSelect Protocol

NCT04240327 is registered in ClinicalTrials.gov with University of Miami as lead sponsor.

NCT NCT04240327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04240327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Marker Driven Selection of Patients for Prostate Biopsy and Management: The University of Miami MDSelect Protocol
Lead sponsor
University of Miami
Phase
Observational
Overall status
Active, not recruiting
Start date
June 29, 2020
Completion date
June 1, 2027
Enrollment
289 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

elevated psa, prostate cancer, psa